Results 201 to 210 of about 107,975 (358)

Ketosis and ketoacidosis in hospitalized patients receiving SGLT2 inhibitor therapy

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The use and safety of sodium‐glucose co‐transporter 2 inhibitors (SGLT2i) in hospital are controversial due to the risk of ketoacidosis. We aimed to describe rates of ketosis, ketoacidosis, and acidosis in patients with type 2 diabetes treated with in‐hospital SGLT2i use.
Frank M. Gao   +8 more
wiley   +1 more source

Factors associated with adherence to antihypertensive agents in the older adult. [PDF]

open access: yesRev Cuid
Silva Fhon JR   +5 more
europepmc   +1 more source

Effects of a new antihypertensive agent, SGB-1534 on platelet aggregation

open access: gold, 1985
Junichiro Aono   +2 more
openalex   +1 more source

A Prospective Comparison of Four Antihypertensive Agents in Daily Clinical Practice [PDF]

open access: bronze, 2001
Carlos Campo   +5 more
openalex   +1 more source

Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP‐4 inhibitors: A multicentre, phase 4 randomized controlled trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the efficacy and safety of three triple‐combination therapies in patients with type 2 diabetes (T2D) inadequately controlled on metformin and a dipeptidyl peptidase‐4 (DPP‐4) inhibitor. Materials and methods This multicentre, prospective, randomised, open‐label, parallel‐group, phase 4 study included patients with T2D ...
Yun Kyung Cho   +10 more
wiley   +1 more source

Doxazosin, an α1-adrenergic antihypertensive agent, decreases serum oxidized LDL [PDF]

open access: bronze, 2001
Makoto Kinoshita   +7 more
openalex   +1 more source

High‐intensity statin therapy is associated with reduced coronary inflammation on CT in patients with type 2 diabetes mellitus

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Pericoronary adipose tissue (PCAT) attenuation, assessed by coronary computed tomography angiography (CCTA), is a biomarker of coronary inflammation. Mean PCAT attenuation ≥ −70.5 Hounsfield Units (HU) corresponds to elevated inflammation and a higher future risk of myocardial infarction.
Bryan Wu, Koen Nieman, Ryan Sandoval
wiley   +1 more source

Home - About - Disclaimer - Privacy